Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCPs vs LNG-IUS for Niche-Related Abnormal Uterine Bleeding
NCT07229209Completed
- Sponsor
- Benha University
- Start
- Feb 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ethinyl estradiol + drospirenone and avatrombopag in abnormal uterine bleeding (AUB) (2 arms), sponsored by Benha University. Primary endpoint: Change in the total number of postmenstrual and/or intermenstrual spotting days per cycle at 6 months. Started Feb 2025; status: completed.
02
Drugs
ethinyl estradiol + drospirenoneavatrombopag
03
Conditions
abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT07229209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07229209.